About Amador
Amador is a Healthcare company based in Pleasanton (United States) founded in 2018. Bioanalytical, pharmacometrics, and related services are provided to clients. Amador has raised $60 million across 2 funding rounds from investors including MSACAP, GL Ventures and Sequoia Capital. Amador has completed 1 acquisition, including A2PG. Amador offers products and services including Bioanalysis and Biomarker Services, Clinical Pharmacology, Regulatory Affairs, and Clinical Research Services. Its focus areas include Biopharma Outsourcing, CRO and Diversified. Its competitors include Charles River Laboratories, Cytel and LabCorp; 1 of its 3 listed competitors has raised funding.
Company details
Amador was founded in 2018 and is based in Pleasanton, United States. Operations focus on the bioscience sector, where bioanalytical and pharmacometrics services are delivered alongside other analytical support. These services assist pharmaceutical and biotech firms in drug development processes. Expertise is applied to quantitative analysis, modeling, and regulatory compliance needs across various therapeutic areas. The company maintains a presence through its domain, amadorbioscience.com, to facilitate client engagements.
- Headquarters Pleasanton, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website amadorbioscience.com
- Social LinkedIn
Products & Services of Amador
Amador offers a comprehensive portfolio of products and services, including Bioanalysis and Biomarker Services, Clinical Pharmacology, Regulatory Affairs, and Clinical Research Services.
Comprehensive services for advancing drug development projects
Techniques to enhance success in drug development programs
Expertise for achieving global regulatory and market goals
Innovative support for worldwide clinical trial execution
Funding Insights of Amador
Amador has successfully raised a total of $60M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60M
- Total Rounds 2
- Last Round Series B — $60M
- Investors Count 5
All 2 funding rounds of Amador with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $60M | Series B | – | MSA | |
| Sep 2021 | Series B | – | Sequoia Capital, GL Ventures |
5 investors in total: 5 institutional.
Investors in Amador
Amador has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include MSACAP, GL Ventures and Sequoia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech companies are invested in by MSA venture capital fund. | msacap.com | Chaoyang, China | ||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
VC fund investing in startups | cowinvc.com | Suzhou, China | ||
| glvllc.com | ||||
| cmbi.com.hk |
Investor details for Amador
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Amador
7 people are tracked at Amador (3 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Nancy Zheng | Associate Director, Clinical Pharmacology | Leadership |
Bing Wang | CEO, Clinical Pharmacology & Pharmacometrics | Leadership |
Ye Lu | Director Of Clinical Pharmacology | Leadership |
Nichelle West | Sr Scientist | Team |
Michele Carlucci | Sr. Associate Scientist | Team |
Xu Liu | Bioanalysis & Biomarkers | Team |
Stacy Brenes | Sr. Data Analyst | Team |
Complete people profiles for Amador
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amador
Amador has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include A2PG.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Data management, pharmacokinetics, and CRO services are provided by A2PG. | a2pg.com | Ann Arbor, United States | 2007 | Dec 2021 | •••• |
Complete acquisition details for Amador
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Amador
4 dated milestones of Amador across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Amador is founded.
- Funding First funding round.
- Acquisition Acquires A2PG.
- Funding Latest funding round, Series B, of $60.0M.
Competitors of Amador
Amador has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, Cytel and LabCorp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | 21,400 | Provider of drug discovery and preclinical development services | ||
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | 9,321 | Provider of laboratory tests for physicians |
Detailed competitors of Amador
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Amador
Websites that share an audience with Amador (amadorbioscience.com).
Websites whose visitors overlap most with Amador. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| apostlebio.com | 100% | 2.7K | #6,461,095 | View details | |
qasource.com | qasource.com | 99% | #1,289,440 | – | |
tscalifornia.com | tscalifornia.com | 98% | – | ||
matchps.com | matchps.com | 98% | #3,460,996 | – | |
| packetfusion.com | 98% | #9,889,933 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Amador
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Amador (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amador
Complete news archive for Amador
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amador
Amador was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Amador is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Amador is a funded company, having raised a total of $60M across 2 funding rounds to date.
Amador was founded in 2018 and is based in Pleasanton, United States. Operations focus on the bioscience sector, where bioanalytical and pharmacometrics services are delivered alongside other analytical support. These services assist pharmaceutical and biotech firms in drug development processes. Expertise is applied to quantitative analysis, modeling, and regulatory compliance needs across various therapeutic areas. The company maintains a presence through its domain, amadorbioscience.com, to facilitate client engagements.
Amador's top competitors include LabCorp, Charles River Laboratories and Cytel.
Amador offers Bioanalysis and Biomarker Services, Clinical Pharmacology, Regulatory Affairs, and Clinical Research Services.
Amador has made 1 acquisition, including A2PG.
Amador has 5 investors. Key investors include MSACAP, GL Ventures, Sequoia Capital, Co-win Ventures, and CMB International Capital.